Highly selective anti-inflammatory drug with gentle and fast-acting formulation based on robenacoxib for cats and dogs, offering long-term use and convenient dosing in two forms
Onoxeb is used in dogs and cats as an anti-inflammatory, antipyretic and analgesic agent for inflammatory and pain syndromes of various origins, including:
Onoxeb is administered to animals individually in tablet form or as a suspension, once a day. It is recommended to give the medication separately from feeding.
The most convenient administration is:
Onoxeb 5 for animals weighing up to 5 kg
Onoxeb 20 for animals weighing from 5 to 20 kg
Onoxeb 40 for animals weighing more than 20 kg
|
Animal weight, kg |
Number of tablets per 1 animal at once |
||
|
Onoxeb 5 |
Onoxeb 20 |
Onoxeb 40 |
|
|
below 2.5 |
½ |
– |
– |
|
2.5 - 5 |
1 |
¼ |
– |
|
5 - 7.5 |
1 ½ |
½ |
– |
|
7.5 - 10 |
2 |
½ |
– |
|
10 - 15 |
– |
¾ |
½ |
|
15 - 20 |
– |
1 |
½ |
|
25 - 30 |
– |
1 ½ |
¾ |
|
30 - 40 |
– |
2 |
1 |
|
40 - 50 |
– |
2 ½ |
1 ¼ |
|
50 - 60 |
– |
3 |
1 ½ |
|
above 60 |
– |
– |
2 |

Contraindications and special instructions:
Hypersensitivity of animals to robenacoxib.
Severe cardiac, renal or hepatic insufficiency.
Dehydration.
Hypovolemia.
Hypotension.
Gastrointestinal ulceration.
Body weight less than 1 kg.